Kanker kolon stadium 4 Dokter Terbaik di Turquia - TOP-9 dokter

Dr. Saban Sec berspesialisasi dalam kanker gastrointestinal, dengan fokus penelitian pada prognosis dan hasil pengobatan kanker kolon.

• Spesialis onkologi medis dengan fokus pada kanker kolon, rektum, dan lambung
• Penelitian yang dipublikasikan mengenai dampak lokalisasi tumor terhadap keberlangsungan hidup pasien kanker kolon
• Anggota Asosiasi Onkologi Medis Turki

Profesor Yıldırım telah menerbitkan lebih dari 80 karya ilmiah dan merupakan spesialis dalam imunoterapi kanker serta terapi target di Pusat Medis Anadolu.

• Memiliki gelar profesor dari Universitas Halic dan merupakan dosen aktif
• Diotorisasi oleh ESMO – salah satu badan onkologi terkemuka di Eropa
• Menjalani pelatihan persekutuan di klinik imunoterapi di London dan Israel
• Memiliki pengalaman lebih dari 21 tahun sebagai spesialis onkologi medis

Dr. Ozden berspesialisasi dalam kanker kolon stadium 4 dengan pengalaman luas di bidang onkologi medis.

• Lulus dari Program Medis Bahasa Inggris Universitas Istanbul
• Menyelesaikan residensi Penyakit Dalam di Fakultas Kedokteran Cerrahpaşa
• Subspesialisasi dalam Onkologi Medis di Universitas Kocaeli
• Praktik di Rumah Sakit Umum Şırnak dan Rumah Sakit Swasta Safa Bağcılar

Spesialis dalam bedah onkologi laparoskopi dan robotik untuk kanker kolon dan rektum dengan pelatihan internasional di lembaga-lembaga terkemuka.

• Melakukan bedah hernia laparoskopi dan menangani penyakit anorektal yang kompleks
• Menjalani pelatihan di University of Colorado Health Science Center dan USC Keck School of Medicine
• Fellow dari European Board of Surgery – Emergency Surgery
• Associate Professor Bedah Umum di Fakultas Kedokteran Istanbul

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spesialis Dr. Rahib Hasanov memadukan pelatihan internasional dengan perawatan onkologi yang dipersonalisasi, dengan fokus pada kasus kanker kolon stadium lanjut.

• Menjalani pelatihan di Houston Methodist Hospital, AS
• Spesialisasi dalam imunoterapi dan terapi target
• Fellowship di bidang Onkologi Medis dari Universitas Marmara
• Menangani pasien dari berbagai negara
• Mengintegrasikan obat pintar terbaru ke dalam perawatan

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.